372 related articles for article (PubMed ID: 32850452)
1. The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review.
König M; Osnes T; Bruland Ø; Sundby Hall K; Bratland Å; Meling TR
Front Oncol; 2020; 10():1402. PubMed ID: 32850452
[No Abstract] [Full Text] [Related]
2. The role of systemic therapy in the management of sinonasal cancer: A critical review.
Bossi P; Saba NF; Vermorken JB; Strojan P; Pala L; de Bree R; Rodrigo JP; Lopez F; Hanna EY; Haigentz M; Takes RP; Slootweg PJ; Silver CE; Rinaldo A; Ferlito A
Cancer Treat Rev; 2015 Dec; 41(10):836-43. PubMed ID: 26255226
[TBL] [Abstract][Full Text] [Related]
3. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.
Hanna E; DeMonte F; Ibrahim S; Roberts D; Levine N; Kupferman M
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1219-24. PubMed ID: 20026819
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine and undifferentiated sinonasal and skull base tumors: An up-to-date narrative review.
Sideris G; Solomos P; Gogoulos P; Margaris I; Panagoulis E; Vlastarakos P; Karamagkiolas S; Tzagkaroulakis M; Nikolopoulos T; Delides A
Oral Maxillofac Surg; 2024 Mar; ():. PubMed ID: 38502274
[TBL] [Abstract][Full Text] [Related]
6. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
[TBL] [Abstract][Full Text] [Related]
7. An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report.
Touihmi S; Horrane I; Rkain I
Ann Med Surg (Lond); 2023 May; 85(5):2029-2033. PubMed ID: 37228980
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment for primary malignant sarcomas arising in craniofacial bones.
Bielack SS
Front Oncol; 2022; 12():966073. PubMed ID: 36158667
[TBL] [Abstract][Full Text] [Related]
9. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center.
Mehta GU; Passer JZ; Raza SM; Kim BYS; Su SY; Kupferman ME; Hanna EY; DeMonte F
J Neurosurg; 2022 Jun; 136(6):1583-1591. PubMed ID: 34624857
[TBL] [Abstract][Full Text] [Related]
10. Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection.
Karp EE; Gompel JJV; Choby G
J Neurol Surg Rep; 2022 Jul; 83(3):e80-e82. PubMed ID: 35832684
[TBL] [Abstract][Full Text] [Related]
11. Radical Exenteration of the Skull Base for End-Stage, Locally Advanced Sinonasal Malignancies: Challenging the Dictum of Unresectability.
Yeung JT; Caminer DM; Young IM; Sughrue ME; Teo C
World Neurosurg; 2021 Jun; 150():e102-e107. PubMed ID: 33647490
[TBL] [Abstract][Full Text] [Related]
12. Personalized Approach to Olfactory Neuroblastoma Care.
Lerner DK; Palmer JN
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673050
[TBL] [Abstract][Full Text] [Related]
13. Management of paranasal sinus malignancy.
Day TA; Beas RA; Schlosser RJ; Woodworth BA; Barredo J; Sharma AK; Gillespie MB
Curr Treat Options Oncol; 2005 Jan; 6(1):3-18. PubMed ID: 15610711
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
[TBL] [Abstract][Full Text] [Related]
15. Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal Tract.
Agaimy A; Baněčková M; De Almeida J; Dickson BC; Dimmler A; Hartmann W; Laé M; Pablik J; Schubart C; Skálová A; Stoehr R; Trautmann M; Wardelmann E; Wassef M; Weinreb I
Am J Surg Pathol; 2023 Mar; 47(3):361-369. PubMed ID: 36580038
[TBL] [Abstract][Full Text] [Related]
16. Sinonasal Malignancies of Anterior Skull Base: Histology-driven Treatment Strategies.
Castelnuovo P; Turri-Zanoni M; Battaglia P; Antognoni P; Bossi P; Locatelli D
Otolaryngol Clin North Am; 2016 Feb; 49(1):183-200. PubMed ID: 26614837
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic versus traditional craniofacial resection for patients with sinonasal tumors involving the anterior skull base.
Kim BJ; Kim DW; Kim SW; Han DH; Kim DY; Rhee CS; Lee CH
Clin Exp Otorhinolaryngol; 2008 Sep; 1(3):148-53. PubMed ID: 19434247
[TBL] [Abstract][Full Text] [Related]
18. Primary mucosal sinonasal melanoma-Case report and review of the literature. The role of complex treatment-surgery and adjuvant radiotherapy.
Marinova L; Yordanov K; Sapundgiev N
Rep Pract Oncol Radiother; 2010; 16(1):40-3. PubMed ID: 24376954
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
20. Extended orbital exenteration for sinonasal malignancy with orbital apex extension: surgical technique and clinical analysis.
Sugawara T; Aoyagi M; Ogishima T; Kawano Y; Tamaki M; Yano T; Tsunoda A; Ohno K; Maehara T; Kishimoto S
J Neurosurg; 2015 Jul; 123(1):52-8. PubMed ID: 25816080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
